Zolgensma

Zolgensma

Active Ingredient:
Onasemnogene Abeparvovec
Origin:
EU

Buy Zolgensma Onasemnogene Abeparvovec

Zolgensma (onasemnogene abeparvovec) is a gene therapy for spinal muscular atrophy (SMA) in pediatric patients. Administered via intravenous infusion, it delivers a functional SMN1 gene to replace the missing or faulty gene causing SMA. This overview covers key details for informational purposes only.

Manufacturer / TM Owner

Novartis Europharm Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Uses / Indications

  • Zolgensma is prescribed to treat spinal muscular atrophy (SMA) in children under two years of age. It is designed for patients with a confirmed SMN1 gene mutation, addressing the root cause of SMA by providing a functional copy of the gene. This gene therapy aims to improve motor function and survival outcomes in affected infants. It is not suitable for all SMA cases, and a healthcare provider should determine eligibility.

Side Effects

  • After administration, Zolgensma works at the genetic level to help produce the SMN protein, which is critical for motor neuron function. Patients may experience gradual improvements in muscle strength and motor skills over time. The effects vary by individual, and regular monitoring by a healthcare professional is recommended to assess progress and adjust care plans as needed.

Precautions & Warnings

  • Zolgensma is administered in a clinical setting by healthcare professionals trained in gene therapy. Patients should be monitored closely for potential side effects, including liver function abnormalities and low platelet counts. Pre-treatment with corticosteroids is often required to manage these risks. Ensure all medical history and current medications are disclosed to the healthcare provider before administration.

Avoid Interactions

  • Zolgensma may interact with medications that affect liver enzymes, such as certain anticonvulsants or immunosuppressants. Corticosteroids are commonly used alongside Zolgensma to mitigate risks, but other drug interactions are not well-documented. Always inform your healthcare provider about all medications, supplements, or herbal products being taken to avoid potential complications.

References

Frequently Asked Questions

Zolgensma is a gene therapy used to treat spinal muscular atrophy (SMA) in children under two years of age with a confirmed SMN1 gene mutation.

Zolgensma is given as a single-dose intravenous infusion in a clinical setting by healthcare professionals.

Common side effects may include liver function changes and low platelet counts; patients are monitored closely during and after treatment.

Eligibility is determined by a healthcare provider based on age, confirmed SMN1 gene mutation, and overall health status.

Zolgensma addresses the genetic cause of SMA but is not a guaranteed cure; individual responses to treatment vary.

Published by GNH India Pharmaceuticals Limited

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT